Prostaglandin inhibition with a dibenzoxazepine hydrazide derivative and morphine.
D000818:Animals; D001920:Bradykinin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002021:Buffers; D003080:Cold Temperature; D003864:Depression, Chemical; D003989:Dibenzoxazepines / Q000494:pharmacology*; D005260:Female; D006168:Guinea Pigs; D006834:Hydrazines / Q000494:pharmacology*; D007082:Ileum; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000187:drug effects* / Q000294:innervation; D009213:Myography; D009994:Osmolar Concentration; D011309:Preservation, Biological; D011448:Prostaglandin Antagonists; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D013464:Sulfuric Acids / Q000008:administration & dosage / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects; D013997:Time Factors
D002021:Buffers; D003989:Dibenzoxazepines; D006834:Hydrazines; D011448:Prostaglandin Antagonists; D012702:Serotonin Antagonists; D013464:Sulfuric Acids; D012701:Serotonin; D009020:Morphine; D001920:Bradykinin